Contact
Please use this form to send email to PR contact of this press release:
CytoDyn’s Monotherapy Trial with Leronlimab (PRO 140) Exceeds Expectations
TO:
Please use this form to send email to PR contact of this press release:
CytoDyn’s Monotherapy Trial with Leronlimab (PRO 140) Exceeds Expectations
TO: